Arkolith/Insider Trading/LIPO/Form 4

Kaufman Jonathan H

See remarks below., Director, 10% OwnerLIPELLA PHARMACEUTICALS INC. (LIPO) · full profile →Form 4 · filed Mar 19, 2024
Net Buying
Open-Market Buys
$45K
Open-Market Sells
$0
Net Open-Market Flow
$45K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2024Buy(P)25K$0.87$22K889K
Mar 18, 2024Buy(P)30K$0.79$24K864K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2024Grant(A)80K—$080K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-24-000573) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML